Philip Evans

A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes

Bernhard Paulweber, Paul Valensi, Jaana Lindström et al. · Hormone and Metabolic Research · 2010 · 478 citations · Full text

Medicine, Chronic Disease Prevention, Preventive Medicine +16

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher Butler, Richard Hobbs, Oghenekome Gbinigie et al. · The Lancet · 2022 · 406 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Christopher Butler, Jienchi Dorward, Ly‐Mee Yu et al. · The Lancet · 2021 · 318 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Ly‐Mee Yu, Mona Bafadhel, Jienchi Dorward et al. · The Lancet · 2021 · 310 citations · Full text

Pharmacy, Community Medicine, Pharmacotherapy +14

Waste the waist: a pilot randomised controlled trial of a primary care based intervention to support lifestyle change in people with high cardiovascular risk

Colin Greaves, Fiona Gillison, Afroditi Stathi et al. · International Journal of Behavioral Nutrition and Physical Activity · 2015 · 306 citations · Full text

Public Health, Chronic Disease Prevention, Health Promotion +17